Log In
BCIQ
Print this Print this
 

NMP22 BladderChek Test (BladderChek)

Also known as: NMP22 test

  Manage Alerts
Collapse Summary General Information
Company Alere Inc.
DescriptionRapid assay to detect nuclear matrix protein in urine
Molecular Target NMP22
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose bladder cancer; Diagnose recurrent bladder cancer; Monitor and test for bladder cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$8,400.0M

$5,800.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/01/2016

$8,400.0M

$5,800.0M

0

Get a free BioCentury trial today